Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed information about Gestational Trophoblastic Neoplasias (GTN) and the addition of a new Phase II trial for avelumab in chemo-resistant GTN patients, along with updates to the revision number.SummaryDifference44%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.